Condition: Femoral Fracture · Sponsor: Zimmer Biomet
Post-market clinical follow-up (PMCF) study to confirm the safety, performance, and clinical benefits of the intra-medullary retrograde femoral nail Zimmer Natural Nail (ZNN) Bactiguard (implants and instrumentation) when used for the temporary internal fixation and stabilization of femoral fractures.
This description comes directly from the study's public registry record.
Gemma de Ramon Francàs · +41 79 377 11 96 · gemma.deramonfrancas@zimmerbiomet.com
Emilie Rohmer · +41 79 368 91 28 · emilie.rohmer@zimmerbiomet.com
Always discuss trial participation with your own doctor first.
| Hospital Universitario Ntra. Sra. de Candelaria | Santa Cruz de Tenerife, Tenerife, Spain | Active Not Recruiting |
| Leeds General Infirmary | Leeds, LEEDS, United Kingdom | Recruiting |
| Manchester Royal Infirmary | Manchester, United Kingdom | Recruiting |
| Stepping Hill Hospital | Stockport, United Kingdom | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05276674